Neoplasm by Morphology — Trials

Neoplasm by Morphology — Trials · CancerIndex

Clinical trials

Registered studies

52,671 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 551–600 of 1,995 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05400577	Sotorasib in KRAS G12C Mutated, Resectable, Stage Ib-IIIA NSCLC	withdrawn	Phase 2	0	Fox Chase Cancer CenterOTHER	1	Jul 17, 2023	clinicaltrials
NCT05109052	Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma	withdrawn	Phase 1 / Phase 2	0	University of RochesterOTHER	1	Jul 13, 2023	clinicaltrials